Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization

Fig. 3

Kaplan Meier analysis of HRQOL for patients who had PCS within 2 standard deviations (SD) vs. those with PCS >2SD below US normalized baseline scores. At 1 month post-Y90, patients with PCS demonstrated: (a) Significantly prolonged median OS (15.7 months vs. 3.7 months; p < 0.001); and (b) Significantly prolonged time to progression (12.4 months vs. 1.8 months; p < 0.001) compared those with physical component scores >2SD below normalized US population values

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us